Project Grant H75DP001753

The Commonwealth of Virginia-State Board of Health, operating through the Richmond City Health District, received a $683,891 cooperative agreement from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The award was made on August 30, 2025, with a five-year performance period through August 29, 2030. The project addresses documented...

This Project Grant award from the National Cancer Institute (NCI) under the Cancer Cause and Prevention Research program (CFDA 93.393) will fund research to develop a minimally invasive, plasma-based diagnostic method for early detection of prostate cancer in African American men. The $475,759 award to The Children's Hospital Corporation (Boston Children's Hospital) will support the investigation of two next-generation sequencing-based methods - cell-free DNA fragmentation profiling and...

This $500,000 Project Grant award from the U.S. Department of Health and Human Services (CFDA 93.493 - Congressional Directives) will enable McLaren Oakland, a 318-bed hospital in Pontiac, Michigan, to purchase a 3D mammography system. The goal is to improve access to state-of-the-art breast cancer screening for the underserved Pontiac community, which has a higher breast cancer incidence rate compared to the state and national averages. The funding will support the establishment of a...

The Florida Department of Health (FDOH) received a $684,000 cooperative agreement awarded August 30, 2025, by the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The five-year award, extending through August 29, 2030, funds the continuation and expansion of Florida's Colorectal Cancer Control Program (CRCCP), building on sixteen years of...

Summary The Alabama Department of Public Health received a $483,280 Cooperative Agreement award dated August 30, 2025, through the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The Alabama Colorectal Cancer Program (ACRCP) will implement evidence-based interventions to increase colorectal cancer screening rates among at-risk Alabama...

Federal Cooperative Agreement Summary Health Research, Inc., through its Center for Community Health division, received a $684,000 cooperative agreement awarded August 30, 2025, by the National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800). The five-year award, extending through August 29, 2030, funds the New York State Department of Health to increase colorectal cancer screening rates...

Federal Cooperative Agreement Summary The Massachusetts Department of Public Health (MDPH) received a $1,079,282 Cooperative Agreement award from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800), effective August 30, 2025 through August 29, 2030. Through this five-year award, MDPH will partner with the Massachusetts League of Community...

Louisiana Colorectal Health Project Grant Summary The Louisiana State University Health Sciences Center New Orleans received a $532,090 Cooperative Agreement from the Centers for Disease Control and Prevention's National Center for Chronic Disease Prevention and Health Promotion under the Organized Approaches to Increase Colorectal Cancer Screening program (CFDA 93.800), awarded August 30, 2025, with a completion date of August 29, 2030. The SCREEN UP initiative will implement evidence-based...

This $500,000 Project Grant award from the Health Resources and Services Administration (HRSA) under the Health Center Program (CFDA 93.224) will support Neighborhood Health, a non-profit community health center in Northern Virginia, in increasing breast and colorectal cancer screening rates among its largely low-income, immigrant, and uninsured patient population. The two-year project aims to remove barriers to accessing and completing cancer screenings by implementing state-of-the-art...

The National Cancer Institute awarded a $1.68M Cooperative Agreement under the 21st Century Cures Act - Beau Biden Cancer Moonshot program (CFDA 93.353) to Kaiser Foundation Hospitals to develop and implement evidence-based strategies for expanding lung cancer screening in Federally Qualified Health Centers (FQHCs). The award, dated September 12, 2025, with an ultimate completion date of August 31, 2027, supports the EXHALE (Expanding Lung Cancer Screening to Achieve Excellence) initiative,...